Skip to main content
. 2022 Nov 17;60(5):2200298. doi: 10.1183/13993003.00298-2022

FIGURE 4.

FIGURE 4

Changes in the proportion of women using a) inhaled corticosteroid (ICS) and b) ICS/long-acting β-agonist (LABA); and changes in c) mean fractional exhaled nitric oxide (FENO) and d) mean Asthma Control Questionnaire (ACQ)7 at visits during pregnancy. Error bars show the 95% confidence intervals.